Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics

Area of Science:

• Biochemistry
• Oncology
• Cell Biology

Background:

• Reactive Oxygen Species (ROS) are crucial for cell signaling, biosynthesis, and host defense.
• Cancer cells exhibit increased ROS production due to carcinogens, mutations, and metabolic reprogramming.
• Elevated ROS levels promote cancer progression and metastasis via downstream survival pathways.

Purpose of the Study:

• To review the intricate relationship between ROS, cancer cell metabolism, and the tumor microenvironment.
• To explore the role of transcription machinery in maintaining redox homeostasis and malignant phenotypes.
• To investigate therapeutic strategies targeting ROS-generating metabolic pathways in cancer.

Main Methods:

• Literature review focusing on the interplay between ROS, cancer metabolism, and therapeutic interventions.
• Analysis of key metabolic pathways and transcription factors involved in redox balance.
• Examination of existing and emerging drugs targeting cancer metabolism.

Main Results:

• Increased ROS production is a hallmark of cancer, driven by metabolic reprogramming.
• ROS signaling pathways are critical for cancer cell survival, proliferation, and metastasis.
• Metabolic interventions targeting ROS production show potential as anti-cancer therapies.

Conclusions:

• Understanding the ROS-metabolism axis is vital for developing novel cancer treatments.
• Targeting metabolic pathways that generate ROS presents a viable therapeutic avenue.
• Further research into drugs like Orlistat, Biguanides, AICAR, 2-Deoxyglucose, CPI-613, and Etomoxir is warranted.